Analyst Ratings for Bright Minds Biosciences Inc. (DRUG)
DRUG Rating Summary
DRUG Price Target Summary
- Highest: $147.00 (BTIG)
- Lowest: $126.00 (Baird)
- Average: $139.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$139.33 (+81.3%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$139.33 (+81.3%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/8/2025 | BTIG » Updated 1/7/2026 |
Thomas Shrader | New Coverage | Buy (N/A) |
147.00 (72.00) |
42.24 (76.87) |
81.98% | Details |
| 5/13/2025 | TD Cowen | Joseph Thome | New Coverage | Buy (N/A) |
N/A (N/A) |
32.49 (76.87) |
136.6% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
